-
02:55:54 AM

GTHP Stock News

11/09/22 10:28 AM
OTC : GTHP
clinical trial
Guided Therapeutics Provides Update of Significant Progress in Chinese Clinical Study for Marketing Approval of the LuViva Advanced Cervical Scan
Guided Therapeutics, Inc., the maker of the LuViva Advanced Cervical Scan, based on its patented biophotonic technology, announced today that the clinical trial for Chinese regulatory is back on track after experiencing delays due to Covid-19 lockdowns and is expected to be completed and filed with the Chinese National Medical...
RHEA-AI
neutral
07/20/22 9:00 AM
OTC : GTHP
clinical trialfda approval
Guided Therapeutics Receives Institutional Review Board Approval to Start Clinical Study for FDA Approval of the LuViva® Advanced Cervical Scan
Guided Therapeutics, Inc., the maker of a rapid and painless testing platform for cervical cancer detection based on its patented biophotonic technology, announced that it has obtained Institutional Review Board approval to initiate its clinical trial aimed at obtaining FDA approval for the Company’ s flagship product, the LuViva...
RHEA-AI
very positive
03/31/22 9:05 AM
OTC : GTHP
clinical trial
Guided Therapeutics Announces Testing Completion of First 150 Patients in Chinese Clinical Study and Receives Milestone Payment of $177,740
Guided Therapeutics, Inc., the maker of the LuViva Advanced Cervical Scan, announced today that testing of 150 patients has been completed in the ongoing clinical trial for Chinese National Medical Products Administration approval. “We are pleased to hear that LuViva has performed well and as expected in the first clinical trials in...
RHEA-AI
neutral
10/05/21 9:05 AM
OTC : GTHP
clinical trial
Guided Therapeutics Ships LuViva Devices to China for Start of Clinical Trial; Receives Additional $100,000 Payment
Guided Therapeutics, Inc., the maker of the LuViva Advanced Cervical Scan, based on its patented biophotonic technology, announced today that its Chinese partner, Shandong Yaohua Medical Instrument Corporation, had received ethics board approval and placed LuViva devices at two of the three participating hospitals for clinical...
RHEA-AI
very positive